Tuesday, October 13, 2015 1:27:34 PM
that sort of cash injection besides covering the costs of national launch activities (inventory build up private label packaging, TV commercials etc) will leave some funds available for share buy back, although he never committed to it - it is one use and would benefit shareholders directly.
of course they cannot have a buy back on current financials it is only with major injections of cash that a multi year licencing deal would bring in that can do that until they start selling by the million month
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM